Using a high-throughput tissue microarray approach consisting of benign prostate hyperplasia and prostate cancer samples, we have validated that ING3 protein levels are elevated in prostate cancer, corresponding to cBioPortal genomic data [32]. This evidence concerns the gene ING3 and Familial prostate cancer.